Etidronate prevents, but does not reverse, ectopic mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6−/−)
Etidronate prevents, but does not reverse, ectopic mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6−/−) |
https://doi.org/10.18632/oncotarget.10738
Qiaoli Li,
Joshua Kingman,
John P. Sundberg,
Michael A. Levine,
and Jouni Uitto
|
30721-30730 |
Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens
Systematic verification of bladder cancer-associated tissue protein biomarker candidates in clinical urine specimens |
https://doi.org/10.18632/oncotarget.24578
Cheng-Han Tsai,
Yi-Ting Chen,
Ying-Hsu Chang,
Chuen Hsueh,
Chung-Yi Liu,
Yu-Sun Chang,
Chien-Lun Chen,
and Jau-Song Yu
|
30731-30747 |
PM2.5 induced cardiac hypertrophy via CREB/GSK3b/SOS1 pathway and metabolomics alterations
PM2.5 induced cardiac hypertrophy via CREB/GSK3b/SOS1 pathway and metabolomics alterations |
https://doi.org/10.18632/oncotarget.25479
Kuan-Lun Li,
and Yen-Chang Lin
|
30748-30760 |
NGAL promotes recruitment of tumor infiltrating leukocytes
NGAL promotes recruitment of tumor infiltrating leukocytes |
https://doi.org/10.18632/oncotarget.25625
Francesco Pacifico,
Luna Pisa,
Stefano Mellone,
Michele Cillo,
Alessio Lepore,
and Antonio Leonardi
|
30761-30772 |
Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents
Selinexor reduces the expression of DNA damage repair proteins and sensitizes cancer cells to DNA damaging agents |
https://doi.org/10.18632/oncotarget.25637
Trinayan Kashyap,
Christian Argueta,
Thaddeus Unger,
Boris Klebanov,
Sophia Debler,
William Senapedis,
Marsha L. Crochiere,
Margaret S. Lee,
Michael Kauffman,
Sharon Shacham,
and Yosef Landesman
|
30773-30786 |
Autophagy-dependent apoptosis is triggered by a semi-synthetic [6]-gingerol analogue in triple negative breast cancer cells
Autophagy-dependent apoptosis is triggered by a semi-synthetic [6]-gingerol analogue in triple negative breast cancer cells |
https://doi.org/10.18632/oncotarget.25704
Liany Luna-Dulcey,
Rebeka Tomasin,
Marina A. Naves,
James A. da Silva,
and Marcia R. Cominetti
|
30787-30804 |
Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing
Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing |
https://doi.org/10.18632/oncotarget.25713
Jenny Rubin,
Sharmineh Mansoori,
Kristin Blom,
Malin Berglund,
Lena Lenhammar,
Claes Andersson,
Angelica Loskog,
Mårten Fryknäs,
Peter Nygren,
and Rolf Larsson
|
30805-30813 |
Cell based functional assays for IDO1 inhibitor screening and characterization
Cell based functional assays for IDO1 inhibitor screening and characterization |
https://doi.org/10.18632/oncotarget.25720
Thomas Richards,
and Elena Brin
|
30814-30820 |
Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells
Silencing of casein kinase 1 delta reduces migration and metastasis of triple negative breast cancer cells |
https://doi.org/10.18632/oncotarget.25738
Isabelle Bar,
Ahmad Merhi,
Lionel Larbanoix,
Manuel Constant,
Sandy Haussy,
Sophie Laurent,
Jean-Luc Canon,
and Paul Delrée
|
30821-30836 |
Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma
Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma |
https://doi.org/10.18632/oncotarget.25745
María Inés Molejon,
Mirna Swayden,
Daniele Fanale,
Jennifer Bintz,
Odile Gayet,
Philippe Soubeyran,
and Juan Iovanna
|
30837-30846 |
Intratumoral immune-biomarkers and mismatch repair status in leiyomyosarcoma -potential predictive markers for adjuvant treatment: a pilot study
Intratumoral immune-biomarkers and mismatch repair status in leiyomyosarcoma -potential predictive markers for adjuvant treatment: a pilot study |
https://doi.org/10.18632/oncotarget.25747
Jonathan E. Cohen,
Feras Eleyan,
Aviad Zick,
Tamar Peretz,
and Daniela Katz
|
30847-30854 |
Influence of age on radiomic features in 18F-FDG PET in normal breast tissue and in breast cancer tumors
Influence of age on radiomic features in 18F-FDG PET in normal breast tissue and in breast cancer tumors |
https://doi.org/10.18632/oncotarget.25762
Sarah Boughdad,
Christophe Nioche,
Fanny Orlhac,
Laurine Jehl,
Laurence Champion,
and Irène Buvat
|
30855-30868 |
Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR
Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR |
https://doi.org/10.18632/oncotarget.25766
Susana Llerena,
Nuria García-Díaz,
Soraya Curiel-Olmo,
Antonio Agraz- Doblas,
Agustín García-Blanco,
Helena Pisonero,
María Varela,
Miguel Santibáñez,
Carmen Almaraz,
Laura Cereceda,
Nerea Martínez,
María Teresa Arias-Loste,
Ángela Puente,
Luis Martín-Ramos,
Carlos Rodríguez de Lope,
Federico Castillo-Suescun,
Carmen Cagigas-Fernandez,
Pablo Isidro,
Carlos Lopez-López,
Marcos Lopez-Hoyos,
Javier Llorca,
Jesús Agüero,
Benedicto Crespo-Facorro,
Ignacio Varela,
Miguel Ángel Piris,
Javier Crespo,
and José Pedro Vaqué
|
30869-30882 |
Association between genetic polymorphisms and platinum-induced ototoxicity in children
Association between genetic polymorphisms and platinum-induced ototoxicity in children |
https://doi.org/10.18632/oncotarget.25767
Gabrielle Lui,
Naïm Bouazza,
Françoise Denoyelle,
Marion Moine,
Laurence Brugières,
Pascal Chastagner,
Nadège Corradini,
Natacha Entz-Werle,
Cécile Vérité,
Judith Landmanparker,
Hélène Sudour-Bonnange,
Marlène Pasquet,
Arnauld Verschuur,
Cécile Faure-Conter,
François Doz,
Jean- Marc Tréluyer,
and On behalf of the SFCE (Société Française des Cancers de l’Enfant et l’Adolescent)
|
30883-30893 |
ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate
ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate |
https://doi.org/10.18632/oncotarget.25768
Nádia Ghinelli Amôr,
Carine Ervolino de Oliveira,
Thaís Helena Gasparoto,
Vanessa Garcia Vilas Boas,
Graziela Perri,
Ramon Kaneno,
Vanessa Soares Lara,
Gustavo Pompermaier Garlet,
João Santana da Silva,
Gislâine A. Martins,
Cory Hogaboam,
Karen A. Cavassani,
and Ana Paula Campanelli
|
30894-30904 |
Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells
Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells |
https://doi.org/10.18632/oncotarget.25773
Chiara Di Stefano,
Paola Grazioli,
Rosaria Anna Fontanella,
Paola De Cesaris,
Antonella D'Amore,
Michele Regno,
Donatella Starace,
Fabrizio Padula,
Micol Elena Fiori,
Rita Canipari,
Antonella Stoppacciaro,
Margherita Pesce,
Antonio Filippini,
Antonio Francesco Campese,
Elio Ziparom,
and Anna Riccioli
|
30905-30918 |
Protection from chemotherapy- and antibiotic-mediated dysbiosis of the gut microbiota by a probiotic with digestive enzymes supplement
Protection from chemotherapy- and antibiotic-mediated dysbiosis of the gut microbiota by a probiotic with digestive enzymes supplement |
https://doi.org/10.18632/oncotarget.25778
Thomas E. Ichim,
Santosh Kesari,
and Kim Shafer
|
30919-30935 |
Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes
Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes |
https://doi.org/10.18632/oncotarget.25856
M. Teresa Cedena,
Inmaculada Rapado,
Alejandro Santos-Lozano,
Rosa Ayala,
Esther Onecha,
María Abaigar,
Esperanza Such,
Fernando Ramos,
José Cervera,
María Díez-Campelo,
Guillermo Sanz,
Jesús Hernández Rivas,
Alejandro Lucía,
and Joaquin Martínez-López
|
30936-30936 |
Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis
Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis |
https://doi.org/10.18632/oncotarget.25857
Michael P. Marciel,
Vedbar S. Khadka,
Youping Deng,
Pascal Kilicaslan,
Andrew Pham,
Pietro Bertino,
Katie Lee,
Suzie Chen,
Natalija Glibetic,
FuKun W. Hoffmann,
Michelle L. Matter,
and Peter R. Hoffmann
|
30937-30937 |